Aurobindo Pharma has received final USFDA approval to manufacture and market Linezolid injection which is an anti-infective and is used to treat infections caused by susceptible gram-positive bacteria in specific conditions. The approved Abbreviated New Drug Application (ANDA) is a bio-equivalent and is therapeutically equivalent to reference listed drug product Zyvox injection of Pharmacia & Upjohn Company. The product, which is expected to be launched in the current quarter, has an estimated market size of $87 million for the 12 months ending June 2016.
Company Profile : Aurobindo Pharma Ltd
Leave a Reply